{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:06:49Z","timestamp":1783656409876,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bioorg.2021.105244","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:17:29Z","timestamp":1628399849000},"page":"105244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity"],"prefix":"10.1016","volume":"115","author":[{"given":"Brodie L.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Gancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Favuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco-Javier","family":"Gamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym N.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey I.","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Laleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Cowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105244_b0005","unstructured":"World Malaria Report; World Health Organisation: Geneva, 2020."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105244_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008900","article-title":"Plasmodium knowlesi infecting humans in Southeast Asia: What's next? PLoS Negl","volume":"14","author":"Jeyaprakasam","year":"2020","journal-title":"Trop. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105244_b0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"New Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0020","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2021.105244_b0025","unstructured":"World Health, O.; World Health Organization. Global Malaria, P. Global technical strategy for malaria, 2016-2030. World Health Organization: 2015; p 29-29."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105244_b0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: A glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7296","key":"10.1016\/j.bioorg.2021.105244_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2020","journal-title":"Nature"},{"issue":"7296","key":"10.1016\/j.bioorg.2021.105244_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.105244_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12936-018-2456-5","article-title":"Plasmodium vivax in vitro continuous culture: the spoke in the wheel","volume":"17","author":"Berm\u00fadez","year":"2018","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105244_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"issue":"6061","key":"10.1016\/j.bioorg.2021.105244_b0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105244_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"issue":"23","key":"10.1016\/j.bioorg.2021.105244_b0065","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0070","doi-asserted-by":"crossref","first-page":"e01804","DOI":"10.1128\/AAC.01804-18","article-title":"Evaluation of 4-amino 2-anilinoquinazolines against Plasmodium and other apicomplexan parasites in vitro and in a P. falciparum humanized NOD-scid IL2R\u03b3(null) mouse model of malaria","volume":"63","author":"Gilson","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/ml200135p","article-title":"An invitation to open Innovation in malaria drug discovery: 47 quality starting points from the TCAMS","volume":"2","author":"Calder\u00f3n","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105244_b0080","unstructured":"Pathogen Box supporting information. https:\/\/www.mmv.org\/mmv-open\/pathogen-box\/pathogen-box-supporting-information."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105244_b0085","doi-asserted-by":"crossref","first-page":"e01053","DOI":"10.1128\/AAC.01053-18","article-title":"Screening the Pathogen Box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds","volume":"62","author":"Calit","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105244_b0090","doi-asserted-by":"crossref","first-page":"e00379","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the Medicines for Malaria Venture Pathogen Box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0095","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.6b01673","article-title":"Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in vivo activity","volume":"60","author":"Gilson","year":"2017","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0100","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1039\/C6GC00902F","article-title":"Formic acid as a sustainable and complementary reductant: an approach to fused benzimidazoles by molecular iodine-catalyzed reductive redox cyclization of o-nitro-t-anilines","volume":"18","author":"Nguyen","year":"2016","journal-title":"Green Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105244_b0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1134\/S1070428020080084","article-title":"Synthesis of quinone derivatives of benzannelated heterocycles with bridgehead nitrogen","volume":"56","author":"Begunov","year":"2020","journal-title":"Russian J. Org. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C4MD00409D","article-title":"The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V","volume":"6","author":"Gazdik","year":"2015","journal-title":"MedChemComm"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105244_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.00079-12","article-title":"Human infections and detection of Plasmodium knowlesi","volume":"26","author":"Singh","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"6220","key":"10.1016\/j.bioorg.2021.105244_b0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105244_b0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12936-015-0962-2","article-title":"Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay","volume":"14","author":"Linares","year":"2015","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105244_b0140","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0145","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/AAC.00433-16","article-title":"Development of a novel high-density [3H]hypoxanthine scintillation proximity assay to assess Plasmodium falciparum growth","volume":"60","author":"De C\u00f3zar","year":"2016","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0150","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches","volume":"25","author":"Ekland","year":"2011","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105244_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2307\/3283363","article-title":"Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity","volume":"80","author":"Yeo","year":"1994","journal-title":"J. Parasitol."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105244_b0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0020-7519(94)00119-9","article-title":"Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro","volume":"24","author":"Yeo","year":"1995","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105244_b0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.27.1.21","article-title":"Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture","volume":"27","author":"Divo","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105244_b0170","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105244_b0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","article-title":"The effects of anti-bacterials on the malaria parasite Plasmodium falciparum","volume":"152","author":"Goodman","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105244_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105244_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000376","article-title":"Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking","volume":"17","author":"Kennedy","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2021.105244_b0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejmech.2018.05.022","article-title":"Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P(2) position of PEXEL peptidomimetics","volume":"154","author":"Nguyen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105244_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113253","article-title":"Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion","volume":"214","author":"Nguyen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"4254","key":"10.1016\/j.bioorg.2021.105244_b0200","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105244_b0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105244_b0210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.01825-12","article-title":"Chemobiosynthesis of new antimalarial macrolides","volume":"57","author":"Goodman","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105244_b0215","unstructured":"Calculator Plugins were used for structure property prediction and calculation, MarvinSketch 6.0.6., 2013, ChemAxon (http:\/\/www.chemaxon.com)."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:38:59Z","timestamp":1758616739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821006210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S0045206821006210"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105244","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105244"}}